Lalitpur pharma park: U.P. eyes one lakh crore investment, 1.5 lakh jobs

A pharma park spanning over 2,000 acres is to come up in Lalitpur, which will accommodate up to 70 manufacturing units.

The park is expected to attract an investment of Rs 1 lakh crore into the state, a press statement issued by the state government on Monday read.

This development is expected to generate more than 1.5 lakh job opportunities. Supporting industries related to pharma will indirectly create 3 lakh jobs, the release read further.

The state government will provide 94 plots in the park, in which plots will range from five acres to 50 acres. This includes three plots of 50 acres, five of 30 acres, eight of 20 acres, 15 plots of 15 acres, 20 plots of 10 acres, and 43 plots of five acres each. Out of the total area, the government will provide plots for industry set-ups in 53%, while the remaining portion will be allocated for other facilities, the statement read.

The park will also allocate 60 acres for residential (housing group) and 40 acres for commercial activities.

Ensuring smooth power supply and upgrading the airport is also in the plan. Additionally, a check-dam reservoir and a pumping station will be constructed on the Jamni River at an estimated cost of 60 crore.

Along with this, about 12 types of concessions will be given to the industry to set up plants in UP. These include interest subsidy, SGST refund, exemption from stamp duty and registration charges, electric duty exemption, EPF reimbursement, hire subsidy, air cargo handling subsidy, patent registration subsidy, quality certification subsidy, skill development incentive, and others.

Related Posts

Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

New Delhi: The entry of semaglutide generics in India is ‘stimulating’ market growth and providing a favourable push to Eli Lilly’s blockbuster brand Mounjaro (tirzepatide), said Patrik Jonsson, Executive Vice…

Pak-made illegal cosmetics recovered from Itwari shop

Nagpur: Maharashtra Food and Drug Administration (FDA), Nagpur Division, raided a cosmetics firm in Itwari market and seized Pakistan-origin beauty products suspected to have harmful mercury and steroids last week. The…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

Pak-made illegal cosmetics recovered from Itwari shop

Pak-made illegal cosmetics recovered from Itwari shop

Licences of 20 medical stores suspended after inspections

Licences of 20 medical stores suspended after inspections

Bain Capital sells nearly 1 pc stake in Emcure Pharma for Rs 289 crore

Bain Capital sells nearly 1 pc  stake in Emcure Pharma for Rs 289 crore

Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

HP accounts for 47 inferior drugs in March alert

HP accounts for 47 inferior drugs in March alert